Showing results (321-330 of 535) with videos related to

Sort By:
Pageof 54
Radiology|December 1, 1983
Myositis ossificans circumscripta: computed tomographic diagnosisM A Amendola, G M Glazer, F P Agha, et al.
Psychoneuroendocrinology|January 1, 1985
Estrogen replacement and tardive dyskinesiaW M Glazer, F Naftolin, H Morgenstern, et al.
Molecular Therapy. Nucleic Acids|October 23, 2025
Cell-penetrating antibody enhances nuclear delivery of triplex-forming oligonucleotides targeting HER2-positive cancersAnthony Minnah, Nicole M García Tubéns, Adam Krysztofiak, et al.
Psychoneuroendocrinology|January 1, 1987
Serum dopamine beta hydroxylase activity and tardive dyskinesiaW M Glazer, H Morgenstern, D V Jeste, et al.
NAR Cancer|December 8, 2025
PARP inhibitor resistance in IDH1-mutant cancers due to loss of end protection factors, 53BP1 and REV7Daniel Andrés Colón-Ríos, Jonathan Dow, Adam Krysztofiak, et al.
Molecular Cancer Research : MCR|September 18, 2021
Vulnerability of IDH1-Mutant Cancers to Histone Deacetylase Inhibition via Orthogonal Suppression of DNA RepairJonathan Dow, Adam Krysztofiak, Yanfeng Liu, et al.
Cancer Research|September 15, 2000
Ionizing radiation-induced apoptosis via separate Pms2- and p53-dependent pathwaysM Zeng, L Narayanan, X S Xu, et al.
Carcinogenesis|May 27, 2006
Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6Denise Campisi Hegan, Latha Narayanan, Frank R Jirik, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|May 31, 2018
Melanoma Reporting Practices of United States DermatologistsRyan M Svoboda, Alex M Glazer, Aaron S Farberg, et al.
Pageof 54